These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1116233)

  • 21. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine.
    El-Sherif N; Scherlag BJ; Lazzara R; Hope RR
    Circulation; 1977 Sep; 56(3):395-402. PubMed ID: 69503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
    Kupersmith J; Cohen R
    J Pharmacol Exp Ther; 1980 Nov; 215(2):394-400. PubMed ID: 7441504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lidocaine on regional intraventricular conduction in patients with coronary artery disease.
    Wiener I; Mindich B; Kupersmith J
    Am Heart J; 1981 Jul; 102(1):53-8. PubMed ID: 7246413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic effects of the new I(Ks)-blocking agent chromanol 293b in the postinfarction canine heart. Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone.
    Bauer A; Becker R; Freigang KD; Senges JC; Voss F; Kraft P; Kuebler W; Schoels W
    Basic Res Cardiol; 2000 Aug; 95(4):324-32. PubMed ID: 11005588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model.
    Nishimoto M; Hashimoto H; Ohmura T; Ikeda Y; Watanabe S; Ohashi K; Umemura K; Nakashima M
    Biol Pharm Bull; 1997 Sep; 20(9):1020-3. PubMed ID: 9331990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of astemizole on ventricular activation, effective refractory periods, RT intervals, and programmed stimulation-induced ventricular arrhythmias in dog hearts with myocardial infarction.
    Hashimoto H; Nishimoto M; Ohmura T; Watanabe S; Ikeda Y; Nakamura R; Umemura K; Nakashima M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):286-91. PubMed ID: 9475271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological effects of flecainide in a canine 7 day old myocardial infarction model.
    Sakai T; Ogawa S; Hosokawa M; Miyazaki T; Sakurai K; Nakamura Y
    Cardiovasc Res; 1989 Mar; 23(3):177-83. PubMed ID: 2512008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intracoronary lidocaine on ventricular arrhythmia in the infarcted canine heart.
    Tordjman T; Raeder E; Lampert S; Lown B
    Pharmacotherapy; 1988; 8(5):295-8. PubMed ID: 3252195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic effects of nitroglycerin during experimental coronary occlusion.
    Levites R; Bodenheimer MM; Helfant RH
    Circulation; 1975 Dec; 52(6):1050-5. PubMed ID: 810264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
    Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
    Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of changes in ventricular excitability and conduction during myocardial ischemia and reperfusion in the dog: effect of lidocaine.
    Avitall B; Naimi S; Levine HJ; Mieszala J
    J Electrocardiol; 1979 Jul; 12(3):271-7. PubMed ID: 89180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
    Hashimoto H; Katoh H; Nakashima M
    J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction.
    Aidonidis I; Brachmann J; Rizos I; Toutouzas P; Kübler W
    Cardiology; 1994; 85(6):378-87. PubMed ID: 7697673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological mechanisms of action of ethmozine that explain its antiarrhythmic efficacy in the late stage of experimental myocardial infarction in dogs.
    Aidonidis I; Egel E; Hilbel T; Rizos I; Kuebler W; Brachmann J
    Eur Heart J; 1994 Dec; 15(12):1698-704. PubMed ID: 7698141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of lidocaine on impulse formation and conduction defects in man.
    Roos JC; Dunning AJ
    Am Heart J; 1975 Jun; 89(6):686-99. PubMed ID: 48330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
    Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
    Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
    Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
    Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.